LC-MS/MS determination of hydrochlorothiazide in human plasma and study its pharmacokinetics
Zou Jian-jun
Abstract
Zou Jian-jun
Abstract
Objective:To establish a method for determination of hydrochlorothiazide in human plasma and study its pharmacokinetics by LC-MS/MS.Methods:20 Healthy volunteers received hydrochlorothiazide tablets(single doses, multidose),drug concentrations in plasma were determined.Results:Pharmacokinetic parameters of hydrochlorothiaz- ide after single oral doses(12.5,25mg)were as follow:T_(1/2β):(13.57±2.39),(10.93±1.71)h;T_(max):(1.85± 0.53),(2.20±0.59)h;C_(max):(74.14±15.04),(125.57±23.47)μg·L~(-1);AUC_(0-48):(470.0±90.7),(794.7± 182.6)μg·h·L~(-1).The essential pharmacokinetic parameters after oral muhidose(12.5mg,qd)were as follow: T_(max)~(SS)(1.83±0.25)h,C_(max)~(SS):(80.21±17.98)μg·L~(-1),C_(min)~(SS):(3.72±1.79)μg·L~(-1),C_(av):(19.37±3.20)μg· L~(-1),AUC_(0-48)~(SS):(464.90±76.89)μg·h·L~(-1).Conclusion:The method is sensitive;the results were accurate;a two -compartment open pharmaeokinetic model is adapted to hydroehlorothiazide plasma concentration-time data analy- sis;the main pharmacokinetic parameters are similar to those reported domestic and abroad.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To establish a method for determination of hydrochlorothiazide in human plasma and study its pharmacokinetics by LC-MS/MS.Methods:20 Healthy volunteers received hydrochlorothiazide tablets(single doses, multidose),drug concentrations in plasma were determined.Results:Pharmacokinetic parameters of hydrochlorothiaz- ide after single oral doses(12.5,25mg)were as follow:T_(1/2β):(13.57±2.39),(10.93±1.71)h;T_(max):(1.85± 0.53),(2.20±0.59)h;C_(max):(74.14±15.04),(125.57±23.47)μg·L~(-1);AUC_(0-48):(470.0±90.7),(794.7± 182.6)μg·h·L~(-1).The essential pharmacokinetic parameters after oral muhidose(12.5mg,qd)were as follow: T_(max)~(SS)(1.83±0.25)h,C_(max)~(SS):(80.21±17.98)μg·L~(-1),C_(min)~(SS):(3.72±1.79)μg·L~(-1),C_(av):(19.37±3.20)μg· L~(-1),AUC_(0-48)~(SS):(464.90±76.89)μg·h·L~(-1).Conclusion:The method is sensitive;the results were accurate;a two -compartment open pharmaeokinetic model is adapted to hydroehlorothiazide plasma concentration-time data analy- sis;the main pharmacokinetic parameters are similar to those reported domestic and abroad.
Key concepts: Pharmacokinetics, Hydrochlorothiazide, Chemistry, Chromatography, Plasma concentration, Human plasma, Pharmacology, Internal medicine